bioXXmed AG
Research bioXXmed AG (T5O.F) on Bullrun: market cap EUR 285.46K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerT5O.F
- ExchangeF
- CountryGermany
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 285.46K
- Financial periodFY2025
- RevenueEUR 16.73K
- Revenue growth378.9%
- Net income-EUR 365.39K
- Free cash flow-EUR 335
Valuation Snapshot
latest market cap is EUR 285.46K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 16.73K | -EUR 365.39K | -EUR 335 | n/a | -1.34 | EUR 203.67K | EUR 385.00K | EUR 0 |
| FY2024 | EUR 3.49K | -EUR 996.91K | -EUR 916 | n/a | -3.67 | EUR 253.86K | EUR 0 | EUR 318.62K |
| FY2023 | EUR 17.40K | -EUR 20.95M | -EUR 730.00K | n/a | -181.39 | EUR 612.83K | EUR 7.26K | EUR 469.94K |
| FY2022 | EUR 12.23K | -EUR 829.84K | -EUR 913.77K | n/a | -7.19 | EUR 1.84M | EUR 0 | EUR 21.42M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | EUR 285.46K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About bioXXmed AG
bioXXmed AG, a holding company, investing in biotechnology and medical technology companies. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is bioXXmed AG's market cap?
bioXXmed AG's market capitalization is EUR 285.46K.
What does bioXXmed AG do?
bioXXmed AG, a holding company, investing in biotechnology and medical technology companies. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany.